28
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Relative Bioavailability of Two Sustained-Release Theophylline Formulations versus an Immediate-Release Preparation

, &
Pages 27-30 | Published online: 02 Jul 2009

References

  • Spangler D L, Kalof D D, Bloom F L, Wittig H G. Theophylline bioavailability following oral administration of six sustained-release preparations. Ann Allergy 1978; 40: 6
  • Spangler D L, Vanderpool G E, Carroll M S, Tinkel-Man D G. Bioavailability and multiple dose characteristics of a new sustained-release theophylline tablet. Ann Allergy 1980; 45: 355
  • Schuppan D, Molz K H, Staib A H, Rietbrock N. Bioavailability of theophylline from a sustained release aminophylline formulation (Euphyllin retard tablets)—Plasma levels after single and multiple oral doses. Int J Clin Pharmacol Therap Toxicol 1981; 19: 223
  • Yeh K C, Kwan K C. A Scientific commentary: A comparison of numerical integrating algorithms by trapezoidal, lagrange, and spline approximation. J Pharmacokin Biopharm 1978; 6: 79
  • Chiou W L. Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. J Pharmacokin Biopharm 1978; 6: 539
  • Wagner J G. Fundamentals of Clinical Pharmacokine-tics, 1st Ed. Drug Intelligence Publications, Hamilton, IL 1975; 174–176

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.